← Open Payments lookup

AYODELE OGUNFOWORA: Open Payments

NPI 1073578506 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$536 in 26 payments from 8 companies in 2025. Trend: 2023 $480 · 2024 $717 · 2025 $536

Food & beverage: $536
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$168
Alkermes, Inc.7$154
Janssen Pharmaceuticals, Inc3$49
ABBVIE INC.2$41
Supernus Pharmaceuticals, Inc.2$39
E.R. Squibb & Sons, L.L.C.2$38
Teva Pharmaceuticals USA, Inc.2$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17

Products named: INGREZZA, ARISTADA, INVEGA SUSTENNA, Qelbree, COBENFY, UZEDY, LYBALVI, VRAYLAR.

Industry payments across SC — which companies pay providers there.